GeneReach Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	104.88	110.27	216.77	748.61	663.43	313.68
Short-Term Investments	135.09	181.01	285.95	-	-	-
Trading Asset Securities	17.39	122.7	-	-	-	-
Cash & Short-Term Investments	257.35	413.98	502.72	748.61	663.43	313.68
Cash Growth	-45.93%	-17.65%	-32.85%	12.84%	111.50%	77.20%
Accounts Receivable	25.74	43.05	21.47	55.86	195.75	165.77
Other Receivables	2.15	3.37	1.68	0.4	0.72	0.66
Receivables	27.9	46.42	23.14	56.26	196.47	166.42
Inventory	36.07	37.52	67.37	235.81	268.3	237.08
Prepaid Expenses	2.59	3.24	5.88	8.36	34.68	31.4
Other Current Assets	143.35	93.51	33.01	21.03	17.66	50.06
Total Current Assets	467.26	594.67	632.14	1,070	1,181	798.64
Property, Plant & Equipment	295.8	359.65	433.83	436.93	397.11	385.56
Long-Term Investments	-	-	-	-	3.24	10.06
Other Intangible Assets	14.07	12.4	12.35	9.49	10.03	8.84
Long-Term Deferred Tax Assets	82.86	83.21	77.65	35.26	24	27.61
Other Long-Term Assets	17.52	16.56	20.18	70.15	69.51	9.81
Total Assets	877.52	1,066	1,176	1,622	1,684	1,241
Accounts Payable	6.34	7.74	8.86	13.35	31.68	31.69
Short-Term Debt	136	171	104	49	49	51
Current Portion of Long-Term Debt	-	-	35.62	204.42	7.5	-
Current Portion of Leases	11.06	11.64	11.38	12.64	8.54	7.72
Current Income Taxes Payable	-	7	3.59	23.08	74.45	55.94
Current Unearned Revenue	2.51	2.93	4.96	7.8	19.43	5.39
Other Current Liabilities	39.21	39.21	37.5	74.8	87.62	93.41
Total Current Liabilities	195.1	239.53	205.9	385.09	278.21	245.14
Long-Term Debt	-	-	-	15	217.39	30
Long-Term Leases	74.64	84.59	97.74	108.89	87.35	99.19
Long-Term Unearned Revenue	9.81	10.57	8.78	8.95	8.82	-
Pension & Post-Retirement Benefits	-	-	-	-	1.73	5.97
Long-Term Deferred Tax Liabilities	6.23	6.29	1.26	1.28	1.2	2.39
Other Long-Term Liabilities	-	0.02	0.02	0.02	1.64	0.06
Total Liabilities	285.79	341	313.71	519.23	596.35	382.75
Common Stock	584.58	574.58	574.58	459.66	417.87	405.9
Additional Paid-In Capital	154.3	144.9	144.9	144.9	144.9	272.72
Retained Earnings	-120.54	-3.29	114.74	464.44	491.74	137.95
Comprehensive Income & Other	-19.26	0.79	-2.15	-1.33	-4.7	-3.56
Total Common Equity	581.77	716.98	832.06	1,068	1,050	813.02
Minority Interest	9.96	8.51	30.37	35.01	38.26	44.74
Shareholders' Equity	591.73	725.49	862.44	1,103	1,088	857.76
Total Liabilities & Equity	877.52	1,066	1,176	1,622	1,684	1,241
Total Debt	221.7	267.23	248.74	389.95	369.78	187.91
Net Cash (Debt)	35.65	146.75	253.98	358.66	293.65	125.78
Net Cash Growth	-82.42%	-42.22%	-29.19%	22.14%	133.48%	23.04%
Net Cash Per Share	0.62	2.55	4.42	6.05	5.01	2.19
Filing Date Shares Outstanding	57.7	57.46	57.46	57.46	57.46	57.46
Total Common Shares Outstanding	57.7	57.46	57.46	57.46	57.46	57.46
Working Capital	272.16	355.14	426.24	684.99	902.32	553.5
Book Value Per Share	10.08	12.48	14.48	18.58	18.27	14.15
Tangible Book Value	567.7	704.59	819.72	1,058	1,040	804.18
Tangible Book Value Per Share	9.84	12.26	14.27	18.42	18.10	14.00
Buildings	293.81	293.85	292.04	267.33	266.03	263.88
Machinery	316.86	332.71	309.58	273.19	231.16	171.49
Construction In Progress	0.08	-	-	20.95	-	0.04

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.